A low-dose, single-pill combination proved to be as effective as — and in some cases, superior to — standard-dose monotherapy ...
New research talks about a promising adjunctive treatment to help people to build a life that isn't run by OCD.
Up to 75% of adolescents experience sleep-related problems, including insufficient duration and poor sleep quality.
Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.
Luvesilocin is a subcutaneously-administered, proprietary prodrug of the psilocybin-like compound 4-OH-DiPT designed to target the serotonin 2A receptor.
MicroTransponder, Inc., a commercial-stage medical device company today announced that it has changed its corporate name to Mobia Medical, Inc. (“Mobia”), effectively immediately. The Company develops ...
Dosing of Cohort 1 complete with first three patients having received starting dose of JAG201 delivered via intracerebroventricular (ICV) injectionFirst two patients in dose-escalation Cohort 2 have ...
The device is administered as a swallowable capsule that is filled with liquid by a physician and naturally leaves the body after approximately 4 months.
Interventions to promote the use of cardiac rehabilitation (CR) programmes may increase enrolment of patients. The interventions probably lead to small increases in patients' attendance of CR ...
Taking ashwagandha for up to three months may improve sleep quality and reduce anxiety and stress. However, its long-term safety beyond this period is not well known.
Adolescence is a period of emotional intensity and rapid psychological change. A new study shows that adolescents with higher ...
Novo’s answer to a closely watched Lilly drug spurred roughly 20% weight loss after 24 weeks in a Phase 2 trial, results one of its executives claimed to be “differentiating.” ...